Patent details

EP2928485 Title: HSP FOR USE IN TREATMENT FOR IMIQUIMOD RELATED SIDE EFFECTS

Basic Information

Publication number:
EP2928485
PCT Application Number:
EP2013075848
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138015888
PCT Publication Number:
WO2014086994
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HSP FOR USE IN TREATMENT FOR IMIQUIMOD RELATED SIDE EFFECTS
French Title of Invention:
PROTÉINES DE CHOC THERMIQUE (HSP) POUR LE TRAITEMENT D'EFFETS SECONDAIRES LIÉS À L'IMIQUIMOD
German Title of Invention:
HSP ZUR VERWENDUNG BEI DER BEHANDLUNG VON IMIQUIMOD-BEDINGTEN NEBENWIRKUNGEN
SPC Number:

Dates

Filing date:
06/12/2013
Grant date:
04/04/2018
EP Publication Date:
14/10/2015
PCT Publication Date:
12/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/04/2018
EP B1 Publication Date:
04/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/12/2018
Expiration date:
06/12/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/03/2018
 
 

Name:
Alfa Biogene International B.V.
Address:
Industrie Strasse 9, 48455 Bad Bentheim, Germany (DE)

Inventor

1

Name:
SEIFARTH, Federico G.
Address:
Germany (DE)

2

Name:
LAX, Julia
Address:
Germany (DE)

Priority

Priority Number:
201261734428 P
Priority Date:
07/12/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 8/49; A61K 8/64; A61K 31/437; A61K 31/4745; A61K 38/01; A61K 38/16; A61P 17/00; A61P 17/02; A61P 17/06; A61P 17/10; A61P 17/12; A61Q 19/00; A61Q 19/06;

Publication

European Patent Bulletin

Issue number:
201814
Publication date:
04/04/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/04/2019 Outgoing Correspondence 1